Cardio Diagnostics Holdings Inc.

Cardio Diagnostics Holdings Inc. Stock Forecast & Price Prediction

Live Cardio Diagnostics Holdings Inc. Stock (CDIO) Price
$0.31

0

Ratings

  • Buy 0
  • Hold 0
  • Sell 0
Disclaimer : Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance. This information is for educational purposes only and should not be construed as advice to buy or sell any security.

Stock Price

$0.31

P/E Ratio

-0.57

Volume Traded Today

$420,547

Dividend

Dividends not available for CDIO

52 Week High/low

3.56/0.17

Cardio Diagnostics Holdings Inc. Market Cap

$9.5M

๐Ÿ›‘ Alert: These ten stocks could have higher potential than $CDIO ๐Ÿ›‘

Before you buy CDIO you'll want to see this list of ten stocks that have huge potential. Want to see if CDIO made the cut? Enter your email below

CDIO Summary

Based on ratings from 0 stock analysts, the Cardio Diagnostics Holdings Inc. stock price is expected to increase by 545.16% in 12 months. This is calculated by using the average 12-month stock price forecast for Cardio Diagnostics Holdings Inc.. The lowest target is $2 and the highest is $2. Please note analyst price targets are not guaranteed and could be missed completely.

CDIO Analyst Ratings

CDIO is a stock in Health Care which has been forecasted to be worth $2 as an average. On the higher end, the forecast price is $2 USD by Bruce Jackson from Benchmark and on the lower end CDIO is forecasted to be $2 by Bruce Jackson from Benchmark.

CDIO stock forecast by analyst

These are the latest 20 analyst ratings of CDIO.

Analyst/Firm

Rating

Price Target

Change

Date

Bruce Jackson
Benchmark

Speculative Buy

$2

Reiterates

Aug 27, 2024
Bruce Jackson
Benchmark

Speculative Buy

$2

Maintains

Jun 6, 2024
Bruce Jackson
Benchmark

Speculative Buy

$1.35

Maintains

Apr 19, 2024
Bruce Jackson
Benchmark

Speculative Buy

$8

Reiterates

Jun 15, 2023
Carl Byrnes
Northland Capital Markets

Outperform

$8

Initiates

May 22, 2023
Bruce Jackson
Benchmark

Speculative Buy

$8

Reiterates

Apr 18, 2023

CDIO Company Information

  • Company Name: Cardio Diagnostics Holdings, Inc.
  • Founded: 2017
  • Headquarters: Chicago, Illinois
  • Business Model: Develops and commercializes epigenetics-based clinical tests for cardiovascular disease
  • Key Products:
    • Epi+Gen CHD: A three-year symptomatic coronary heart disease risk assessment test
    • PrecisionCHD: An integrated epigenetic-genetic blood test for early detection of coronary heart disease
  • Target Conditions: Focuses on coronary heart disease events, including heart attacks
CDIO
Cardio Diagnostics Holdings Inc. (CDIO)

When did it IPO

2022

Staff Count

7

Country

United States

Sector/Industry

Healthcare/Biotechnology

CEO

Dr. Meeshanthini V. Dogan Ph.D.

Market Cap

$9.5M

Cardio Diagnostics Holdings Inc. (CDIO) Financial Data

In 2023, CDIO generated $17,065 in revenue, which was a increase of 1,696.32% from the previous year. This can be seen as a signal that CDIO's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2020

$0

Revenue From 2021

$901

0.00 %
From Previous Year

Revenue From 2022

$950

5.44 %
From Previous Year

Revenue From 2023

$17,065

1,696.32 %
From Previous Year
  • Revenue TTM $39,138
  • Operating Margin TTM -16,295.6%
  • Gross profit TTM $0
  • Return on assets TTM -98.0%
  • Return on equity TTM -293.3%
  • Profit Margin 0.0%
  • Book Value Per Share 0.13%
  • Market capitalisation $9.5M
  • Revenue for 2021 $901
  • Revenue for 2022 $950
  • Revenue for 2023 $17,065
  • EPS this year (TTM) $-0.40

Cardio Diagnostics Holdings Inc. (CDIO) Latest News

News Image

Mon, 29 Jul 2024

Sentiment - NEUTRAL

Source - Business Wire

Summary - CHICAGO--(BUSINESS WIRE)--CDIO.AI emphasizes Cardio Diagnostics' AI-first, scalable solutions for preventing, detecting and managing cardiovascular disease.

News Image

Tue, 25 Jun 2024

Sentiment - NEUTRAL

Source - Business Wire

Summary - CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics will sponsor a booth and showcase its groundbreaking cardiovascular solutions at the 2024 Onsite Employee Health Clinics Forum.

News Image

Thu, 27 Jun 2024

Sentiment - NEUTRAL

Source - Business Wire

Summary - CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics' clinical blood test, Epi+Gen CHD is now available at FMS' retail clinical location at the Meijer Supercenter in McHenry, IL.

News Image

Mon, 10 Jun 2024

Sentiment - NEUTRAL

Source - Business Wire

Summary - CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics today announced the successful completion of its System and Organization Controls (SOC) 2 Type I audit.

News Image

Tue, 21 May 2024

Sentiment - NEUTRAL

Source - Business Wire

Summary - CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics will recommend pricing for its Epi+Gen CHD and PrecisionCHD tests, and pursue coverage via the MolDx program.

News Image

Mon, 13 May 2024

Sentiment - NEUTRAL

Source - Business Wire

Summary - CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics' clinical blood tests are now available at FMS' newest clinical location at the Walmart Supercenter in Round Lake Beach, Illinois.

...

CDIO Frequently asked questions

The highest forecasted price for CDIO is $2 from Bruce Jackson at Benchmark.

The lowest forecasted price for CDIO is $2 from Bruce Jackson from Benchmark

The CDIO analyst ratings consensus are 0 buy ratings, 0 hold ratings, and 0 sell ratings.